175 related articles for article (PubMed ID: 37746259)
1. Lipids, cholesterols, statins and liver cancer: a Mendelian randomization study.
Liang Z; Zhang Z; Tan X; Zeng P
Front Oncol; 2023; 13():1251873. PubMed ID: 37746259
[TBL] [Abstract][Full Text] [Related]
2. Associations of Lipids and Lipid-Lowering Drugs with Risk of Vascular Dementia: A Mendelian Randomization Study.
Zhang X; Geng T; Li N; Wu L; Wang Y; Zheng D; Guo B; Wang B
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615727
[TBL] [Abstract][Full Text] [Related]
3. Causal effects of circulating lipids and lipid-lowering drugs on the risk of urinary stones: a Mendelian randomization study.
Tan Z; Hong J; Sun A; Ding M; Shen J
Front Endocrinol (Lausanne); 2023; 14():1301163. PubMed ID: 38107516
[TBL] [Abstract][Full Text] [Related]
4. Causal effects of circulating lipids and lipid-lowering drugs on the risk of epilepsy: a two-sample Mendelian randomization study.
Liang Z; Zhao L; Lou Y; Liu S
QJM; 2023 Jun; 116(6):421-428. PubMed ID: 36964718
[TBL] [Abstract][Full Text] [Related]
5. Mendelian randomization study of lipid metabolism characteristics and migraine risk.
Hong P; Han L; Wan Y
Eur J Pain; 2024 Jul; 28(6):978-986. PubMed ID: 38183343
[TBL] [Abstract][Full Text] [Related]
6. The causal effects of lipid traits on kidney function in Africans: bidirectional and multivariable Mendelian-randomization study.
Kintu C; Soremekun O; Kamiza AB; Kalungi A; Mayanja R; Kalyesubula R; Bagaya S B; Jjingo D; Fabian J; Gill D; Nyirenda M; Nitsch D; Chikowore T; Fatumo S
EBioMedicine; 2023 Apr; 90():104537. PubMed ID: 37001235
[TBL] [Abstract][Full Text] [Related]
7. Plasma lipids, alcohol intake frequency and risk of Osteoarthritis: a Mendelian randomization study.
Wen MT; Liang XZ; Luo D; Li JC; Yan BZ; Lu BW; Xu B; Li G
BMC Public Health; 2023 Jul; 23(1):1327. PubMed ID: 37434151
[TBL] [Abstract][Full Text] [Related]
8. The Causal Relationship Between Blood Lipids and Systemic Lupus Erythematosus Risk: A Bidirectional Two-Sample Mendelian Randomization Study.
Wang M; Huang S; Lin X; Wen C; He Z; Huang L
Front Genet; 2022; 13():858653. PubMed ID: 35495122
[No Abstract] [Full Text] [Related]
9. Genetic association of lipids and lipid-lowering drugs with sepsis: a Mendelian randomization and mediation analysis.
Lou C; Meng Z; Shi YY; Zheng R; Qian SZ; Pan J
Front Cardiovasc Med; 2023; 10():1217922. PubMed ID: 37621565
[TBL] [Abstract][Full Text] [Related]
10. Association of lipid-lowering drugs with COVID-19 outcomes from a Mendelian randomization study.
Huang W; Xiao J; Ji J; Chen L
Elife; 2021 Dec; 10():. PubMed ID: 34866576
[TBL] [Abstract][Full Text] [Related]
11. Can Lipid-Lowering Drugs Reduce the Risk of Cholelithiasis? A Mendelian Randomization Study.
Dong H; Chen R; Xu F; Cheng F
Clin Epidemiol; 2024; 16():131-141. PubMed ID: 38410417
[TBL] [Abstract][Full Text] [Related]
12. Genetically proxied therapeutic inhibition of lipid-lowering drug targets and risk of rheumatoid arthritis disease: a Mendelian randomization study.
Qiao L; Lv S; Meng K; Yang J
Clin Rheumatol; 2024 Mar; 43(3):939-947. PubMed ID: 38198113
[TBL] [Abstract][Full Text] [Related]
13. Causal effect between total cholesterol and HDL cholesterol as risk factors for chronic kidney disease: a mendelian randomization study.
Miao L; Min Y; Qi B; Zhu CM; Chen JH; Deng GX; Wang Y; Li JF; Li RS
BMC Nephrol; 2021 Jan; 22(1):35. PubMed ID: 33472594
[TBL] [Abstract][Full Text] [Related]
14. Association between genetically proxied lipid-lowering drug targets, lipid traits, and amyotrophic lateral sclerosis: a mendelian randomization study.
Yan Z; Xu Y; Li K; Liu L
Acta Neurol Belg; 2024 Apr; 124(2):485-494. PubMed ID: 37889424
[TBL] [Abstract][Full Text] [Related]
15. The Relationship between Blood Lipids and Risk of Atrial Fibrillation: Univariable and Multivariable Mendelian Randomization Analysis.
Yang S; Pudasaini R; Zhi H; Wang L
Nutrients; 2021 Dec; 14(1):. PubMed ID: 35011056
[TBL] [Abstract][Full Text] [Related]
16. Circulating lipids, lipid-lowering drug targets, and breast cancer risk: Comprehensive evidence from Mendelian randomization and summary data-based Mendelian randomization.
Zhang Z; Zhang D
Cancer Causes Control; 2024 Jun; 35(6):983-994. PubMed ID: 38430374
[TBL] [Abstract][Full Text] [Related]
17. Lipids, Apolipoproteins, Statins, and Intracerebral Hemorrhage: A Mendelian Randomization Study.
Yu Z; Zhang L; Zhang G; Xia K; Yang Q; Huang T; Fan D
Ann Neurol; 2022 Sep; 92(3):390-399. PubMed ID: 35655417
[TBL] [Abstract][Full Text] [Related]
18. Association between lipid-lowering drugs and allergic diseases: A Mendelian randomization study.
Xu Y; Li Y
World Allergy Organ J; 2024 Apr; 17(4):100899. PubMed ID: 38623319
[TBL] [Abstract][Full Text] [Related]
19. The Association between Circulating Lipids and Female Infertility Risk: A Univariable and Multivariable Mendelian Randomization Analysis.
Zhu X; Hong X; Wu J; Zhao F; Wang W; Huang L; Li J; Wang B
Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513548
[TBL] [Abstract][Full Text] [Related]
20. A causal association between lipid-lowering medications and rotator cuff syndrome: a drug-targeted mendelian randomization study.
Liu MM; Chen X; Yu CW; Chen JW; Zhen PX; Liu ZP
Front Genet; 2024; 15():1383646. PubMed ID: 38903760
[No Abstract] [Full Text] [Related]
[Next] [New Search]